Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN HENEGAN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1114188471
CMS profile
1380215
Location
JACKSON, MS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$4,116.94

198 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,970.46 196
Education $146.48 2

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $332.82 10
Novartis Pharmaceuticals Corporation $279.92 17
PFIZER INC. $266.98 16
Incyte Corporation $198.32 16
Janssen Biotech, Inc. $190.66 10
Takeda Pharmaceuticals U.S.A., Inc. $170.77 8
Merck Sharp & Dohme LLC $167.74 8
Astellas Pharma US Inc $152.35 7
Celgene Corporation $149.42 7
ABBVIE INC. $148.03 6
Regeneron Healthcare Solutions, Inc. $115.84 5
Daiichi Sankyo Inc. $109.99 5
BeOne Medicines USA, Inc. $101.36 5
GENZYME CORPORATION $96.65 5
Caris MPI, Inc. $95.04 1
Exelixis Inc. $85.25 4
SEAGEN INC. $77.99 1
GlaxoSmithKline, LLC. $77.77 4
Rigel Pharmaceuticals, Inc. $74.17 3
Karyopharm Therapeutics Inc. $72.99 4
PharmaEssentia USA Corporation $67.43 3
Adaptive Biotechnologies Corporation $63.98 3
Genentech USA, Inc. $62.80 3
ADC THERAPEUTICS AMERICA, INC. $59.44 3
Bayer Healthcare Pharmaceuticals Inc. $57.48 3
Gilead Sciences, Inc. $57.01 2
Geron Corporation $51.60 2
Aveo Pharmaceuticals, Inc. $51.21 3
Blueprint Medicines Corporation $51.20 1
SANOFI-AVENTIS U.S. LLC $48.71 2
Emmaus Medical, Inc. $46.88 3
Alnylam Pharmaceuticals Inc. $46.43 3
Alexion Pharmaceuticals, Inc. $46.08 2
Dendreon Pharmaceuticals LLC $44.01 2
JAZZ PHARMACEUTICALS INC. $41.54 2
SANOFI US SERVICES INC. $40.22 2
Agios Pharmaceuticals, Inc. $39.99 2
Boehringer Ingelheim Pharmaceuticals, Inc. $36.83 2
ARRAY BIOPHARMA INC $31.62 2
SOBI, INC $30.07 1
SpringWorks Therapeutics, Inc. $30.06 2
Novo Nordisk Inc $22.85 1
E.R. Squibb & Sons, L.L.C. $22.21 1
Stemline Therapeutics Inc. $19.48 1
Lilly USA, LLC $18.43 1
Genmab U.S., Inc. $16.58 1
Legend Biotech USA Inc. $16.37 1
SERVIER PHARMACEUTICALS LLC $16.27 1
TOLMAR, INC. $16.10 1

Page 4 of 4; records 151–198 of 198 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN HENEGAN

NPI 1114188471 · CMS profile ID 1380215

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

JACKSON, MS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–198 of 198 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1114188471?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN HENEGAN, NPI 1114188471, CMS profile ID 1380215. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–198 of 198 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1114188471?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JOHN HENEGAN, NPI 1114188471, CMS profile ID 1380215. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–198 of 198 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1114188471?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JOHN HENEGAN, NPI 1114188471, CMS profile ID 1380215, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–198 of 198 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1114188471?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

198 matching records · $4,116.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 198 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–198 of 198.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $19.7403/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175018169 CMS
Blueprint Medicines Corporation $51.2003/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235813741 CMS
Incyte Corporation $18.2603/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226136096 CMS
Daiichi Sankyo Inc. $17.1903/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197092949 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.8603/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222898955 CMS
Adaptive Biotechnologies Corporation $24.6303/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254934989 CMS
Rigel Pharmaceuticals, Inc. $27.2603/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247370802 CMS
Incyte Corporation $20.5903/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226050467 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.5003/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223878061 CMS
SANOFI US SERVICES INC. $19.7103/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233474478 CMS
ARRAY BIOPHARMA INC $18.4802/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230523343 CMS
Celgene Corporation $28.4402/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937109 CMS
PFIZER INC. $9.5102/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230548135 CMS
Alexion Pharmaceuticals, Inc. $23.3302/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202958604 CMS
Lilly USA, LLC $18.4302/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186736175 CMS
ABBVIE INC. $23.8502/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202032413 CMS
Novartis Pharmaceuticals Corporation $14.2402/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200208847 CMS
Celgene Corporation $20.4202/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937091 CMS
Alnylam Pharmaceuticals Inc. $18.1002/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212771747 CMS
Daiichi Sankyo Inc. $25.9502/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197097993 CMS
Novartis Pharmaceuticals Corporation $27.4902/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200208845 CMS
GENZYME CORPORATION $16.3802/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233474396 CMS
Emmaus Medical, Inc. $15.6202/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1161388619 CMS
Rigel Pharmaceuticals, Inc. $22.1702/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247369555 CMS
Exelixis Inc. $19.2402/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218795985 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.1102/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223849855 CMS
Dendreon Pharmaceuticals LLC $22.7701/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245002315 CMS
Novo Nordisk Inc $22.8501/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189071902 CMS
Celgene Corporation $19.8701/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937081 CMS
ABBVIE INC. $30.6501/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202032411 CMS
PFIZER INC. $20.3601/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230520833 CMS
Dendreon Pharmaceuticals LLC $21.2401/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245002313 CMS
Novartis Pharmaceuticals Corporation $17.0401/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200208843 CMS
Genentech USA, Inc. $20.3001/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211524826 CMS
Daiichi Sankyo Inc. $29.3901/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197072521 CMS
Incyte Corporation $0.4401/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226071685 CMS
Merck Sharp & Dohme LLC $15.4501/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238192568 CMS
Celgene Corporation $21.5501/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937085 CMS
Incyte Corporation $1.4501/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226053349 CMS
PFIZER INC. $20.8101/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230523375 CMS
AstraZeneca Pharmaceuticals LP $14.5501/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206967510 CMS
Incyte Corporation $16.9501/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226066072 CMS
AstraZeneca Pharmaceuticals LP $22.4501/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206440976 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.2801/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223891174 CMS
Karyopharm Therapeutics Inc. $17.3501/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246646883 CMS
AstraZeneca Pharmaceuticals LP $16.1201/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206854707 CMS
Astellas Pharma US Inc $18.7301/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238718828 CMS
Regeneron Healthcare Solutions, Inc. $24.1201/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212941265 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,207.36 150
PY2020 $842.31 37
PY2021 $4,185.47 56
PY2022 $10,608.00 67
PY2023 $10,247.88 79
PY2024 $2,814.44 139
PY2025 $4,116.94 198

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $117,176.00 4
PY2024 Principal investigator $187,195.66 8
PY2023 Principal investigator $678,969.94 12
PY2022 Principal investigator $123,915.40 11
PY2021 Principal investigator $2,415.00 1
PY2020 Principal investigator $18,500.00 1
PY2019 Principal investigator $173.77 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Caris MPI, Inc. $8,500.00 12/22/2025 Covered Recipient Teaching Hospital
UNIVERSITY OF MISSISSIPPI MEDICAL
THE CARIS BIOREPOSITORY RESEARCH PROTOCOL No dispute reported 06/30/2026 1234284260
Principal investigator 1 Novartis Pharmaceuticals Corporation $66,396.22 02/05/2025 Non-covered Recipient Entity
UNIVERSITY OF MISSISSIPPI MISSISSIPPI MEDICAL CENTER
An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) No dispute reported 06/30/2026 1190300319
Principal investigator 1 AstraZeneca UK Limited $274.93 01/17/2025 Covered Recipient Teaching Hospital
University Of Mississippi Medical
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer No dispute reported 06/30/2026 1185540011
Principal investigator 1 Novartis Pharmaceuticals Corporation $42,004.85 01/15/2025 Non-covered Recipient Entity
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER CANCER AND RESEARCH INSTITUTE
An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) No dispute reported 06/30/2026 1190302187